Telomir Pharmaceuticals Ownership | Who Owns Telomir Pharmaceuticals?

Telomir Pharmaceuticals Ownership Summary

Telomir Pharmaceuticals is owned by 4.00% institutional investors, 35.11% insiders, and 60.89% retail investors. Vanguard group is the largest institutional shareholder, holding 3.66% of TELO shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 1.63% of its assets in Telomir Pharmaceuticals shares.

TELO Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Telomir Pharmaceuticals	4.00%	35.11%	60.89%
Sector	Healthcare Stocks	35.56%	12.08%	52.36%
Industry	Biotech Stocks	35.43%	12.01%	52.56%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Vanguard group	1.14M	3.66%	$1.51M
Blackrock funding, inc. /de	289.20K	0.84%	$375.96K
Geode capital management	249.09K	0.72%	$323.95K
Vanguard fiduciary trust	135.54K	0.39%	$176.20K
Millennium management	129.06K	0.38%	$167.78K
Raymond james financial	75.34K	0.25%	$104.72K
State street	58.60K	0.17%	$76.18K
Bank of new york mellon	51.45K	0.15%	$66.89K
Northern trust	41.84K	0.12%	$54.40K
Pensionmark financial group	37.04K	0.11%	$48.15K

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Praetorian wealth management	20.00K	0.01%	$26.60K
Morton capital management llc/ca	12.66K	0.00%	$16.46K
Pensionmark financial group	37.04K	0.00%	$48.15K
Xtx topco	36.06K	0.00%	$46.88K
Resources investment advisors, llc.	23.00K	0.00%	$29.90K
Kestra private wealth services	11.00K	0.00%	$14.30K
Vestmark advisory solutions	13.10K	0.00%	$17.03K
Millennium management	129.06K	0.00%	$167.78K
Advisor group	35.80K	0.00%	$46.53K
Regions financial	10.64K	0.00%	$13.83K

Top Buyers

Holder	Shares	% Assets	Change
Vanguard fiduciary trust	135.54K	-	135.54K
Raymond james financial	75.34K	-	73.55K
Vanguard group	1.14M	-	35.71K
Geode capital management	249.09K	-	25.54K
Goldman sachs group	10.41K	-	10.41K

Top Sellers

Holder	Shares	% Assets	Change
Marshall wace, llp	-	-	-75.77K
Y-intercept (hong kong)	-	-	-64.42K
Suncoast equity management	-	-	-51.19K
Charles schwab investment management	-	-	-46.41K
Hightower advisors	-	-	-43.00K

New Positions

Holder	Shares	% Assets	Change	Value
Vanguard fiduciary trust	135.54K	-	135.54K	$176.20K
Vanguard global advisers	6.55K	-	6.55K	$8.52K
Allworth financial lp	12.00	-	12.00	$15.00

Sold Out

Holder	Change
Citigroup	-1.00
Caitong asset management	-2.00
Barclays	-2.00
True wealth design	-3.00
Srs capital advisors	-9.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Mar 31, 2026	15	-54.55%	1,376,196	-39.79%	4	7.38%	6	-50.00%	1	-85.71%
Dec 31, 2025	25	-19.35%	1,978,496	-15.17%	6	10.55%	8	-42.86%	6	-53.85%
Sep 30, 2025	18	-53.85%	1,901,652	-26.54%	6	8.38%	6	-75.00%	9	-35.71%
Jun 30, 2025	42	-	2,793,154	-24.36%	9	6.10%	25	19.05%	16	14.29%
Mar 31, 2025	42	13.51%	3,694,173	7.09%	12	9.12%	21	-32.26%	14	-

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Vanguard Total Stock Mkt Idx Inv	1.12M	1.63%	305.77K
Vanguard Morn Total Stk Mkt Idx Investor	1.12M	1.63%	305.77K
Vanguard Institutional Extnd Mkt Idx Tr	472.62K	0.69%	258.50K
Fidelity Extended Market Index	210.79K	0.31%	89.34K
Extended Equity Market Fund B	41.02K	0.06%	-
Blackrock Extended Mkt Fund CF	41.02K	0.06%	-
Extended Equity Market Fund E	41.02K	0.06%	-
NT Ext Equity Mkt Index Fund - NL	40.02K	0.06%	19.69K
iShares Micro-Cap ETF	36.68K	0.05%	-490.00
BlackRock Extended Equity Market Fund K	34.86K	0.05%	-64.00

Recent Insider Transactions

Date	Name	Role	Activity	Value
Feb 13, 2024	Bay Shore Trust	-	Buy	$343.00K
Feb 13, 2024	Bay Shore Trust	-	Buy	$343.00K
Feb 13, 2024	Bay Shore Trust	-	Buy	$280.00K

Insider Transactions Trends

Date	Buy	Sell
2026 Q2	-	-
2025 Q3	-	-
2025 Q2	-	-
2024 Q4	-	-
2024 Q3	-	-

TELO Ownership FAQ

Who Owns Telomir Pharmaceuticals?

Telomir Pharmaceuticals shareholders are primarily institutional investors at 4.00%, followed by 35.11% insiders and 60.89% retail investors. The average institutional ownership in Telomir Pharmaceuticals's industry, Biotech Stocks , is 35.43%, which Telomir Pharmaceuticals falls below.

Who owns the most shares of Telomir Pharmaceuticals?

Telomir Pharmaceuticals’s largest shareholders are Vanguard group (1.14M shares, 3.66%), Blackrock funding, inc. /de (289.2K shares, 0.84%), and Geode capital management (249.09K shares, 0.72%). Together, they hold 5.23% of Telomir Pharmaceuticals’s total shares outstanding.

Does Blackrock own Telomir Pharmaceuticals?

BlackRock is not among the top 10 institutional shareholders of Telomir Pharmaceuticals.

Who is Telomir Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Praetorian wealth management is Telomir Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 0.01% of its assets in 20K Telomir Pharmaceuticals shares, valued at 26.6K$.

Who is the top mutual fund holder of Telomir Pharmaceuticals shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Telomir Pharmaceuticals shares, with 1.63% of its total shares outstanding invested in 1.12M Telomir Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools